Biotech · Private company · Portland, OR, US
Surgivance, Inc.
Track this companyFree. Adds Surgivance, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demandFiscal year 2026 · $1.3MNIH RePORTER 5R44CA302122-02 · fetched Nov 12, 2026
- Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demandFiscal year 2025 · $978.2KNIH RePORTER 1R44CA302122-01 · fetched Nov 12, 2026
- Advanced Surgical Pathology DeviceFiscal year 2024 · $1MNIH RePORTER 5R44CA235915-03 · fetched Nov 12, 2026